Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China flag China · Delayed Price · Currency is CNY
3.380
+0.010 (0.30%)
Feb 27, 2026, 3:04 PM CST

SHE:002390 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
6,4108,6298,5609,13614,42313,431
Market Cap Growth
-18.94%0.81%-6.31%-36.66%7.39%58.53%
Enterprise Value
6,1978,8208,9329,84115,45415,772
Last Close Price
3.384.474.264.466.957.94
PE Ratio
88.6185.1129.8040.7252.8677.40
Forward PE
-26.3326.3324.7429.3529.35
PS Ratio
1.121.431.331.442.232.30
PB Ratio
0.921.231.201.292.112.60
P/TBV Ratio
1.071.461.411.522.493.28
P/FCF Ratio
11.2116.9213.0721.1570.6322.24
P/OCF Ratio
9.6113.5910.8315.4631.4918.10
EV/Sales Ratio
1.081.461.381.552.392.70
EV/EBITDA Ratio
13.8217.9614.4117.3320.1424.83
EV/EBIT Ratio
24.8131.1822.8429.5729.2439.08
EV/FCF Ratio
10.8417.2913.6422.7875.6826.11
Debt / Equity Ratio
0.080.110.120.200.210.66
Debt / EBITDA Ratio
1.171.581.332.421.825.37
Debt / FCF Ratio
0.921.541.283.226.935.65
Net Debt / Equity Ratio
-0.06-0.030.000.070.120.32
Net Debt / EBITDA Ratio
-0.99-0.460.050.871.032.57
Net Debt / FCF Ratio
-0.76-0.450.051.143.872.71
Asset Turnover
0.660.660.680.650.670.58
Inventory Turnover
5.184.855.155.225.765.00
Quick Ratio
2.812.232.021.651.561.12
Current Ratio
3.582.912.632.162.021.36
Return on Equity (ROE)
1.76%2.20%4.98%3.86%6.23%4.32%
Return on Assets (ROA)
1.79%1.93%2.57%2.14%3.43%2.51%
Return on Invested Capital (ROIC)
3.19%3.40%4.74%3.75%6.51%4.60%
Return on Capital Employed (ROCE)
3.50%3.90%5.40%4.70%7.70%7.80%
Earnings Yield
1.20%1.18%3.36%2.46%1.89%1.29%
FCF Yield
8.92%5.91%7.65%4.73%1.42%4.50%
Dividend Yield
1.78%1.34%1.41%1.35%0.86%-
Payout Ratio
231.87%189.67%55.09%75.03%84.41%113.85%
Buyback Yield / Dilution
-7.11%-5.89%-2.41%-2.79%-15.32%-0.14%
Total Shareholder Return
-5.33%-4.55%-1.00%-1.44%-14.46%-0.14%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.